Irhythmtech
NASDAQ: IRTCSan Francisco, US · Delaware corporation · 3 known investors
iRhythm provides wearable cardiac monitoring devices and AI-powered analysis services for clinicians to diagnose heart arrhythmias. The platform combines engineered ECG monitors, machine learning algorithms, and expert clinical review to deliver actionable diagnostic reports.
Founders & leadership
KM
Kevin M. KingExecutive Officer, Director
TA
Tiba AynechiDirector
JL
Joshua L. GreenDirector
CD
Casper de ClercqDirector
CE
Chris E. GrantDirector
WN
William N. StarlingDirector
RS
Raymond ScottDirector
VK
Vijay K. LathiDirector
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$27.3MraisedMar 2015 · 10 investors · Other Health CareRule 506(b)
▶$27.3MraisedMar 2015 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kevin M. KingExecutive Officer, Director
- Tiba AynechiDirector
- Joshua L. GreenDirector
- Casper de ClercqDirector
- Chris E. GrantDirector
- William N. StarlingDirector
- Raymond ScottDirector
- Vijay K. LathiDirector
- Offering amount
- $29.5M
- Amount sold
- $27.3M
- Minimum investment
- $1
- First sale
- May 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.